Within the tumour microenvironment, the majority of CD8+ T cells in the NIR-PIT and combination groups were Klrg1-positive, suggesting that most tumour-infiltrating CD8+ T cells had differentiated into effector cells following treatment. This evidence concerns the gene CD8A and neoplasm.